Pacific Biosciences

NASDAQ:PACB   3:59PM EDT
5.64
+0.17 (+3.11%)
StockTwits Share  Twitter Share  Facebook Share

Search For a Symbol

Market Cap (Intraday)861.13M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats...
Estimates Current Quarter
Revenue$26.7 Million
Adjusted EPS-$0.15
See more estimates...
10-Day MA$5.55
50-Day MA$5.57
200-Day MA$6.73
See more pivots...

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Stock, NASDAQ:PACB

1305 O'BRIEN DRIVE, MENLO PARK, CA 94025
United States of America
Phone: 650-521-8000
Number of Employees: 438

Description

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company's single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes biochemical sequencing reactions. The company also provides consumable products, including SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distributors in Asia, the Middle East, and Latin America. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.